ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.

Hara, Yasuo; Zheng, Zuoyu; Evans, Susan C; Malatjalian, Dickran; Riddell, D Christie; Guernsey, Duane L; Wang, Li Dong; Riabowol, Karl; Casson, Alan G

Hara, Yasuo; Zheng, Zuoyu; Evans, Susan C; Malatjalian, Dickran; Riddell, D Christie; Guernsey, Duane L; Wang, Li Dong; Riabowol, Karl; Casson, Alan G.

Affiliation

Hara Y; Departments of Biochemistry, Molecular Biology and Oncology, University of Calgary, Calgary, Alberta T2N 1N2, Canada.

Cancer Lett ; 192(1): 109-16, 2003 Mar 20.

Article in En | MEDLINE | ID: mdl-12637159

Subject(s)

Adenocarcinoma/genetics; Adenocarcinoma/pathology; Esophagogastric Junction/pathology; Genes, p53/genetics; Mutation/genetics; Proteins/genetics; Proteins/metabolism; Base Sequence; Cell Cycle Proteins; DNA Mutational Analysis; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Inhibitor of Growth Protein 1; Intracellular Signaling Peptides and Proteins; Nuclear Proteins; Polymorphism, Single-Stranded Conformational; RNA, Messenger/genetics; RNA, Messenger/metabolism; Tumor Suppressor Proteins

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Proteins / Genes, p53 / Esophagogastric Junction / Mutation Limits: Humans Language: En Journal: Cancer Lett Year: 2003 Document type: Article Affiliation country: Canada Country of publication: Ireland

Search on Google

Add to My VHL

XML

PubMed Links